IRIS
CORRADO, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 7.857
NA - Nord America 6.289
AS - Asia 3.551
SA - Sud America 1.119
Continente sconosciuto - Info sul continente non disponibili 196
AF - Africa 102
OC - Oceania 10
Totale 19.124
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.127
RU - Federazione Russa 4.043
SG - Singapore 1.501
CN - Cina 1.126
BR - Brasile 947
IE - Irlanda 879
SE - Svezia 823
DE - Germania 407
IT - Italia 373
HK - Hong Kong 346
UA - Ucraina 289
FR - Francia 284
PL - Polonia 212
VN - Vietnam 191
GB - Regno Unito 186
FI - Finlandia 181
IN - India 102
CA - Canada 73
AR - Argentina 64
MX - Messico 47
BD - Bangladesh 46
BE - Belgio 46
JP - Giappone 31
TR - Turchia 31
ZA - Sudafrica 30
NL - Olanda 29
IQ - Iraq 26
EC - Ecuador 25
MA - Marocco 25
ES - Italia 24
PK - Pakistan 22
VE - Venezuela 18
ID - Indonesia 17
UZ - Uzbekistan 17
AT - Austria 16
CO - Colombia 16
CZ - Repubblica Ceca 13
UY - Uruguay 12
AE - Emirati Arabi Uniti 11
SA - Arabia Saudita 11
AZ - Azerbaigian 10
PE - Perù 10
AL - Albania 9
KE - Kenya 9
AU - Australia 8
CL - Cile 8
JM - Giamaica 8
PH - Filippine 8
PY - Paraguay 8
RO - Romania 8
TN - Tunisia 8
EG - Egitto 7
IR - Iran 7
KZ - Kazakistan 7
BO - Bolivia 6
CI - Costa d'Avorio 6
JO - Giordania 6
LT - Lituania 6
MY - Malesia 6
CR - Costa Rica 5
DO - Repubblica Dominicana 5
GY - Guiana 5
HN - Honduras 5
NI - Nicaragua 5
BB - Barbados 4
GT - Guatemala 4
KR - Corea 4
LU - Lussemburgo 4
NP - Nepal 4
RS - Serbia 4
DZ - Algeria 3
GE - Georgia 3
IL - Israele 3
KH - Cambogia 3
LV - Lettonia 3
NG - Nigeria 3
PT - Portogallo 3
SN - Senegal 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
BW - Botswana 2
BY - Bielorussia 2
CG - Congo 2
CH - Svizzera 2
EE - Estonia 2
GR - Grecia 2
HU - Ungheria 2
KG - Kirghizistan 2
NZ - Nuova Zelanda 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BG - Bulgaria 1
BH - Bahrain 1
DK - Danimarca 1
ET - Etiopia 1
EU - Europa 1
GA - Gabon 1
GD - Grenada 1
IS - Islanda 1
LA - Repubblica Popolare Democratica del Laos 1
Totale 18.920
Salva come PNG Salva come JPEG
Città #
Ashburn 1.094
Moscow 1.065
Singapore 887
Dublin 878
Chandler 643
Jacksonville 576
Dallas 533
Nyköping 431
Beijing 398
Hong Kong 346
San Jose 318
Warsaw 193
Boardman 160
Ann Arbor 157
The Dalles 157
Los Angeles 153
Lauterbourg 131
Princeton 129
Cambridge 127
Messina 120
Munich 111
Medford 110
Dearborn 106
Des Moines 101
São Paulo 81
Ho Chi Minh City 68
Buffalo 63
Woodbridge 61
New York 57
Santa Clara 54
Brussels 46
Shenyang 40
Tianjin 40
Jinan 39
Catania 38
Frankfurt am Main 37
Turku 37
Wilmington 36
Bremen 35
Hanoi 34
Council Bluffs 32
Guangzhou 31
Hyderabad 29
Orem 28
Tokyo 27
Belo Horizonte 26
Düsseldorf 26
Houston 26
Montreal 26
Hebei 25
Lancaster 25
Nanjing 25
Chennai 24
London 24
Redondo Beach 24
Zhengzhou 24
Brooklyn 23
Helsinki 23
Rio de Janeiro 23
Denver 22
San Mateo 21
Seattle 21
Washington 20
Shanghai 19
Stockholm 19
Amsterdam 17
Curitiba 17
Porto Alegre 17
Boston 16
Johannesburg 16
Atlanta 15
Hangzhou 15
Ningbo 15
Brasília 14
Haikou 14
Manchester 14
Tashkent 14
Chicago 13
Mexico City 13
San Francisco 13
Sorocaba 13
Auburn Hills 12
Baghdad 12
Dong Ket 12
Ottawa 12
Taizhou 12
Mumbai 11
Pune 11
Shenzhen 11
Da Nang 10
Milan 10
Phoenix 10
Quito 10
Toronto 10
Wroclaw 10
Baku 9
Campinas 9
Guayaquil 9
Jakarta 9
Nanchang 9
Totale 10.737
Salva come PNG Salva come JPEG
Nome #
Myo-inositol Supplementation for Prevention of Gestational Diabetes in Obese Pregnant Women: A Randomized Controlled Trial 248
Breast safety and efficacy of genistein aglycone for postmenopausal bone loss: a follow-up study 237
Adiponectin and insulin resistance in early- and late-onset pre-eclampsia 229
Metabolic effects of breastfeeding in women with previous gestational diabetes diagnosed according to the IADPSG criteria 220
Myo-inositol may prevent gestational diabetes onset in overweight women: a randomized, controlled trial 219
Italian risk factor-based screening for gestational diabetes. 208
Association between maternal serum high mobility group box 1 levels and pregnancy complicated by gestational diabetes mellitus 208
ADAM 12 and PAPP-A at 14–17 weeks' gestation as biomarkers of pre-eclampsia. 207
Perinatal outcome in a Caucasian population with gestational diabetes and preexisting diabetes first diagnosed in pregnancy 205
A single abnormal value of the glucose tolerance test is related to increased adverse perinatal outcome. 204
Association of Gestational Weight Gain With Maternal and Infant Outcomes: A Systematic Review and Meta-analysis 202
Clinical and metabolic outcomes in pregnant women at risk for gestational diabetes mellitus supplemented with myo-inositol: a secondary analysis from 3 RCTs 202
A 45,MALE WITH MOLECULAR EVIDENCE OF A TRANSLOCATION OF Y EUCHROMATIN ONTO CHROMOSOME 1 199
Abnormal glucose tolerance later in life in women affected by glucose intolerance during pregnancy 196
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes. 194
Effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome: a perspective, randomized, placebo-controlled study. 192
Myo-inositol may prevent gestational diabetes in PCOS women 191
Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 1-year randomized, double-blind, placebo-controlled study 190
A 45,X MALE WITH MOLECULAR EVIDENCE OF A TRANSLOCATION OF Y- EUCHROMATIN ONTO CHROMOSOME-1 187
Abortività spontanea ed età materna avanzata. 187
OPG and sRANKL serum concentrations in osteopenic, postmenopausal women after 2-year genistein administration. 184
Cardiovascular effects of raloxifene hydrochloride 184
Effects of myo-inositol on glucose variability in women with gestational diabetes 183
Cardiac diastolic evaluation in pregnant women with abnormal glucose tolerance: an opportunity to detect the early and subclinical alterations and prevent cardiovascular diseases 180
C-reactive protein as an early predictor of gestational diabetes mellitus 179
Effects of the phytoestrogen genistein on some predictors of cardiovascular risk in osteopenic, postmenopausal women: A two-year randomized, double-blind, placebo-controlled study 178
Effects of the phytoestrogen genistein on hot flushes, endometrium and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebo controlled study. 176
Screening for gestational diabetes in Sicily. 175
Intravaginal vs. intracervical PGE(2) gel first application for labor induction 172
Peroxisome proliferator-activated receptor modulation during metabolic diseases and cancers: master and minions 172
GENISTEIN AGLYCONE DOES NOT AFFECT THYROID FUNCTION: RESULTS FROM A THREE-YEAR, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL 171
Efficacy of genistein aglycone on some cardiovascular risk factors and homocysteine levels: A follow-up study 170
One-year effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome 170
Glucose Tolerance and insulin secretion in pregnancy 169
First trimester serum neutrophil gelatinase-associated lipocalin in gestational diabetes 169
First trimester serum PAPP-A and NGAL in the prediction of late-onset pre-eclampsia. 169
Wnt antagonist sclerostin and Dickkopf-1 in gestational diabetes 169
Cardiovascular effects of the phytoestrogen genistein 168
"Anticorpi antifosfolipidi ed aborto ricorrente". 167
Neutrophil gelatinase-associated lipocalin serum evaluation through normal pregnancy and in pregnancies complicated by preeclampsia. 167
Celiac disease in pregnancy: not always a relapse 166
Plasma homocysteine in early and late pregnancies complicated with preeclampsia and isolated intrauterine growth restriction 165
Improvement of selective screening strategy for gestational diabetes through a more accuratedefinition of high-risk groups 163
EFFECTS OF THE PHYTOESTROGEN GENISTEIN ON CARDIOVASCULAR RISK FACTORS IN POSTMENOPAUSAL WOMEN. 163
PREGNANCY IN ESSENTIAL THROMBOCYTHEMIA DURING ASPIRIN TREATMENT 162
Compliance with hormone replacement therapy in postmenopausal Sicilian women 162
Positive association between a single abnormal glucose tolerance test value in pregnancy and subsequent abnormal glucose tolerance 162
Maternal serum PAPP-A as an early marker of obstetric complications? 160
A randomised trial of progesterone prophylaxis after midtrimester amniocentesis 159
Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: A randomized double-blind placebo-controlled study 159
ICAM-1 in maternal serum and amniotic fluid as an early marker of preeclampsia and IUGR 158
Myo-inositol supplementation to prevent gestational diabetes in overweight non-obese women: bioelectrical impedance analysis, metabolic aspects, obstetric and neonatal outcomes–a randomized and open-label, placebo-controlled clinical trial 158
First trimester serum PAPP-A and NGAL in the prediction of late-onset preeclampsia 157
Myo-inositol supplementation and the onset of gestational diabetes mellitus in pregnant women with a family hystory of type 2 diabetes. A prospective, randomized, placebo controlled study 155
Effects of genistein on hot flushes in early postmenopausal women: a randomized, double-blind EPT- and Placebo-controlled Study 154
Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women - A randomized trial 154
Effects of a phyto complex on well-being of climacteric women 153
Is mid-trimester maternal serum inhibin-A a marker of preeclampsia or intrauterine growth restriction? 152
CORRESPONDENCE BETWEEN FIRST TRIMESTER FASTING GLICEMIA AND ORAL GLUCOSE TOLERANCE TEST IN GESTATIONAL DIABETES DIAGNOSIS 152
Endoglin, PlGF and sFlt-1 as markers for predicting pre-eclampsia. 151
Differences in body composition between post-menopausal women with and without dyslipidemia. 150
Midtrimester amniotic fluid adiponectin in normal pregnancy. 149
Effects of the phytoestrogen genistein on the circulating soluble receptor activator of nuclear factor kappa B ligand-osteoprotegerin system in early postmenopausal women 149
Plasma adiponectin concentration in early pregnancy and subsequent risk of hypertensive disorders 148
Diagnosis of gestational diabetes mellitus: italian perspectives on risk factor based screening 148
Randomized double-blind study evaluating the efficacy on uterine fibroids shrinkage and on intra-operative blood loss of different length of leuprolide acetate depot treatment before myomectomy 147
Effects of the phytoestrogen genistein on hot flushes, endometrium and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebo-controlled study 144
Pregnancy outcome following mid-trimester amniocentesis 143
SCLEROSTIN AND DICKKOPF-1 IN PREGNANT WOMEN WITH GESTATIONAL DIABETES 141
Midtrimester Amniotic Fluid Leptin and Insulin Levels and Subsequent Gestational Diabetes. 139
Effects of prepregnancy body mass index and weight gain during pregnancy on perinatal outcome in glucose-tolerant women. 139
The phytoestrogen alpha-zearalenol reverses endothelial dysfunction induced by oophorectomy in rats 138
Myoinositol plus α‑lactalbumin supplementation, insulin resistance and birth outcomes in women with gestational diabetes mellitus: a randomized, controlled study 138
Anti-SARS-CoV2 IgG are present in the amniotic fluid of both infected and vaccinated women at second trimester of pregnancy: a cohort study 137
Screening for gestational diabetes in Sicily 137
Second trimester neutrophil gelatinase-associated lipocalin as a potential prediagnostic marker of preeclampsia. 136
La disfunzione diastolica nel diabete gestazionale 136
Modalità di prelievo in corso d'amniocentesi ed outcome ostetrico 136
A 45,X male with molecular evidence of a translocation of Y euchromatin onto chromosome 1 134
Diagnosis of celiac disease in pregnancy and puerperium: think about it 134
Effects of a New Flavonoid and Myo-Inositol Supplement on Some Biomarkers of Cardiovascular Risk in Postmenopausal Women: A Randomized Trial 133
Sindrome mano-piede-utero. Descrizione di un caso ad ereditarietà autosomica recessiva. 130
Spontaneous abortion and advanced maternal age 130
Effect of genistein on endothelial function in postmenopausal women: A randomized, double-blind, controlled study 129
Prevalenza dei fattori di rischio associati al diabete gestazionale e alla ridotta tolleranza glucidica in gravidanza 129
Myo-inositol in Down syndrome amniotic fluid. A case-control study. 129
Hand-foot-uterus syndrome: a report of a case with recessive autosomal inhereditance 128
Myo-Inositol for the Prevention of Gestational Diabetes Mellitus. A Brief Review 128
Prevalence of risk factors in the screening of carbohydrate intolerance in pregnancy 127
VALUTAZIONE LONGITUDINALE DI DONNE CON RIDOTTA TOLLERANZA GLUCIDICA IN GRAVIDANZA 125
Intolleranza glucidica e disordini ipertensivi in gravidanza. 125
Role of urocortin in pregnancy: an update and future perspectives 123
TESTICULAR REGRESSION SYNDROME - A CASE-REPORT 122
Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma NO concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women 122
Predittività dell’OGTT sugli outcomes clinici ed ostetrici nella ridotta tolleranza glucidica in gravidanza 118
La disfunzione diastolica nel diabete gestazionale 117
Livelli serici di OPG e RANKL in donne osteopeniche in post-menopausa, trattate per 2 anni col fitoestrogeno genisteina 116
Inflammatory markers in women with a recent history of gestational diabetes mellitus 113
Prenatally identified Pallister-Killian syndrome: Ultrasound pattern and diagnostic considerations 111
The effect of the phytoestrogen genistein and hormone replacement therapy on homocysteine and C-reactive protein level in postmenopausal women. 108
Totale 16.048
Salva come PNG Salva come JPEG
Categoria #
all - tutte 62.309
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.309
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022979 11 155 18 28 35 11 60 37 24 239 105 256
2022/20232.621 181 260 140 171 218 263 15 155 1.094 15 82 27
2023/2024703 54 96 46 97 64 113 16 21 7 46 7 136
2024/20252.796 44 34 52 196 127 114 43 583 674 200 283 446
2025/20269.016 504 554 550 597 680 1.909 1.066 1.205 1.265 371 156 159
2026/2027123 123 0 0 0 0 0 0 0 0 0 0 0
Totale 19.124